Beijing Inno Medicine Co., Ltd. clinical trial pipeline

5 trials changed in the last 30 days: 2 stopped, 1 with a notable change, 2 with minor changes only.

1. Stopped

   YN001-004 · Coronary Atherosclerosis in Australia

   Trial terminated

   Also in this update: Final enrollment: 3 participants (planned 24)

   Beijing Inno Medicine Co., Ltd.·Phase 2· NCT06700720· Registry history of NCT06700720 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

2. Stopped

   YN001 in Healthy Participants

   Recruitment suspended

   Also in this update: Primary completion pushed from Feb 4, 2026 to Sep 2026; Study completion pushed from Feb 18, 2026 to Sep 2026

   Beijing Inno Medicine Co., Ltd.·Phase 1· NCT07190885· Registry history of NCT07190885 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

3. Notable

   YN001 · Atherosclerotic Cardiovascular and Cerebrovascular…YN001 · Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

   Recruitment opened

   Also in this update: Primary completion pushed from Jun 16, 2026 to Oct 2026

   Beijing Inno Medicine Co., Ltd.·Phase 2· NCT07311330· Registry history of NCT07311330 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.